{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:40:46Z","timestamp":1786984846447,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.atherosclerosis.2016.07.923","type":"journal-article","created":{"date-parts":[[2016,7,31]],"date-time":"2016-07-31T15:14:02Z","timestamp":1469978042000},"page":"82-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Angiographic progression of coronary atherosclerosis in patients with familial hypercholesterolaemia treated with non-statin therapy: Impact of a fat-modified diet and a resin"],"prefix":"10.1016","volume":"252","author":[{"given":"Gerald F.","family":"Watts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.H.","family":"Brunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib1","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease (Consensus Statement of the European Atherosclerosis Society)","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijcard.2013.11.025","article-title":"Integrated guidance on the care of familial hypercholesterolaemia from the international FH foundation","volume":"171","author":"Watts","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the american college of cardiology\/american heart association task force on practice guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/MOL.0000000000000238","article-title":"The hinterland of familial hypercholesterolaemia: what do we not know?","volume":"26","author":"Wierzbicki","year":"2015","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib5","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/eurheartj\/ehn422","article-title":"Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study","volume":"29","author":"Neil","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib6","doi-asserted-by":"crossref","first-page":"a2423","DOI":"10.1136\/bmj.a2423","article-title":"Efficacy of statins in familial hypercholesterolaemia: a long term cohort study","volume":"337","author":"Versmissen","year":"2008","journal-title":"Br. Med. J."},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.5551\/jat.4143","article-title":"Impact of statin treatment on the clinical fate of heterozygous familial hypercholesterolemia","volume":"17","author":"Harada-Shiba","year":"2010","journal-title":"J.\u00a0Atheroscler. Thromb."},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib8","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.111.042523","article-title":"Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy","volume":"124","author":"Raal","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib9","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/S0735-1097(02)02593-7","article-title":"Early statin therapy restores endothelial function in children with familial hypercholesterolemia","volume":"40","author":"de Jongh","year":"2002","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0140-6736(00)04053-8","article-title":"Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial","volume":"357","author":"Smilde","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib11","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy\u2014European atherosclerosis society consensus panel statement on assessment, aetiology and management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosissup.2014.04.001","article-title":"The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice","volume":"15","author":"Sattar","year":"2014","journal-title":"Atheroscler. Suppl."},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib13","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/MOL.0000000000000236","article-title":"Statin intolerance","volume":"26","author":"Laufs","year":"2015","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib14","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1016\/j.jacc.2014.03.019","article-title":"Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab","volume":"63","author":"Stroes","year":"2014","journal-title":"J. Am. Coll. Cardiol"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40273-015-0355-y","article-title":"PCSK9 inhibitors: a technology worth paying for?","volume":"34","author":"Weintraub","year":"2016","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib16","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/0002-9149(93)90010-A","article-title":"Importance of diet in the treatment of familial hypercholesterolemia","volume":"72","author":"Connor","year":"1993","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.1984.03340270029025","article-title":"The Lipid Research Clinics Coronary Primary Prevention Trial results, I. Reduction in incidence of coronary heart disease","volume":"251","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.1984.03340270043026","article-title":"The Lipid Research Clinics Coronary Primary Prevention Trial results, II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering","volume":"251","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/01.CIR.69.2.313","article-title":"Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study","volume":"69","author":"Brensike","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib20","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1001\/jama.1987.03390230069027","article-title":"Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts","volume":"257","author":"Blankenhorn","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib21","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1001\/jama.1990.03450230049028","article-title":"Beneficial effects of colestipol-niacin on coronary atherosclerosis: a 4-year follow-up","volume":"264","author":"Cashin-Hemphill","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib22","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJM199011083231901","article-title":"Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B","volume":"323","author":"Brown","year":"1990","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib23","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1001\/jama.1990.03450230043027","article-title":"Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens","volume":"264","author":"Kane","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib24","series-title":"Bile Acid Sequestrants","author":"Goldberg","year":"2015"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0140-6736(92)90863-X","article-title":"Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)","volume":"339","author":"Watts","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib26","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/1350-4533(95)97315-G","article-title":"Quantitative coronary cineangiography for the study of atherosclerosis","volume":"17","author":"Brunt","year":"1995","journal-title":"Med. Eng. Phys."},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib27","series-title":"Familial Hypercholesterolaemia. Report of a Second WHO Consultation","author":"World Health Organization","year":"1999"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/CIRCIMAGING.110.962001","article-title":"Imaging biomarkers in atherosclerosis trials","volume":"4","author":"Tardif","year":"2011","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib29","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1161\/CIRCULATIONAHA.112.144055","volume":"126","author":"Raal","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib30","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1056\/NEJM199010043231404","article-title":"Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH): effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolaemia","volume":"323","author":"Buchwald","year":"1990","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib31","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jama.1992.03490110067031","article-title":"Changes in sequential coronary arteriograms and subsequent coronary events","volume":"268","author":"Buchwald","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib32","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/SLA.0b013e3181deb4d0","article-title":"Overall mortality, incremental life expectancy, and cause of death at 25 Years in the program on the surgical control of the Hyperlipidemias","volume":"251","author":"Buchwald","year":"2010","journal-title":"Ann. Surg."},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib33","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.atherosclerosis.2012.07.030","article-title":"Genetic analysis of familial hypercholesterolaemia in Western Australia","volume":"224","author":"Hooper","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0140-6736(90)91656-U","article-title":"Can lifestyle changes reverse coronary heart disease?: the Lifestyle Heart Trial","volume":"336","author":"Ornish","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.CIR.86.1.1","article-title":"Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease","volume":"86","author":"Schuler","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib36","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2014.01.063","article-title":"Lipoprotein (a) levels in Familial Hipercholesterolaemia: an important predictor for cardiovascular disease independent of the type of LDL-receptor mutation","volume":"63","author":"Alonso","year":"2014","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib37","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(95)92961-4","article-title":"Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis","volume":"345","author":"Thompson","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1161\/01.CIR.84.1.412","article-title":"Quantitative coronary angiography to measure progression and regression of coronary atherosclerosis","volume":"84","author":"de Feyter","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib39","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/01.CIR.87.4.1067","article-title":"Prognostic significance of progression of coronary atherosclerosis","volume":"87","author":"Waters","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ahj.2016.01.019","article-title":"Impact of PCSK9 inhibition on coronary atheroma progression: rationale and design of global assessment of plaque regression with a PCSK9 antibody as measured by intravascular ultrasound (GLAGOV)","volume":"176","author":"Puri","year":"2016","journal-title":"Am. Heart J."},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib41","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1093\/clinchem\/40.12.2240","article-title":"Metabolic determinants of the course of coronary artery disease in men","volume":"40","author":"Watts","year":"1994","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib42","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/ajcn\/64.2.202","article-title":"Dietary fatty acids and progression of coronary artery disease in men","volume":"64","author":"Watts","year":"1996","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib43","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/0140-6736(93)90634-S","article-title":"Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients","volume":"341","author":"Leung","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib44","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/01.ATV.11.3.569","article-title":"Quantitative studies of transfer in\u00a0vivo of low density, Sf 12-60, and Sf 60-400 lipoproteins between plasma and arterial intima in humans","volume":"11","author":"Shaikh","year":"1991","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.atherosclerosis.2014.02.007","article-title":"A\u00a0systematic review of the time course of atherosclerotic plaque regression","volume":"234","author":"Noyes","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib46","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jama.297.5.499","article-title":"Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis","volume":"297","author":"Nicholls","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2796.2012.02584.x","article-title":"Oxidized LDL level is related to gene expression of tumour necrosis factor super family members in children and young adults with familial hypercholesterolaemia","volume":"273","author":"Narverud","year":"2013","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib48","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0026-0495(95)90256-2","article-title":"Serum sialic acid as an indicator of change in coronary artery disease","volume":"44","author":"Watts","year":"1995","journal-title":"Metabolism."},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/hrt.73.3.209","article-title":"Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis","volume":"73","author":"Ye","year":"1995","journal-title":"Br. Heart J."},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib50","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa1200303","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet","volume":"368","author":"Estruch","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.07.923_bib51","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/01.CIR.99.6.779","article-title":"Mediterranean diet, traditional risk factors and rate of cardiovascular complications after myocardial infartion. Final Report of the Lyon Diet Heart Study.","volume":"99","author":"Lorgeril","year":"1999","journal-title":"Circulation"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016312242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016312242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T03:56:04Z","timestamp":1761191764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915016312242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":51,"alternative-id":["S0021915016312242"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.07.923","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiographic progression of coronary atherosclerosis in patients with familial hypercholesterolaemia treated with non-statin therapy: Impact of a fat-modified diet and a resin","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.07.923","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}